Literature DB >> 2904619

Acute hepatitis after treatment of acromegaly with octreotide.

M Arosio, N Bazzoni, B Ambrosi, G Faglia.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 2904619     DOI： 10.1016/s0140-6736(88)90982-8

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  3 in total

1.  The prophylactic use of octreotide in a patient with ovarian carcinoid and valvular heart disease.

Authors:  J T Watson; N H Badner; M J Ali
Journal:  Can J Anaesth       Date:  1990-10       Impact factor: 5.063

Review 2.  Clinical pharmacokinetics of octreotide. Therapeutic applications in patients with pituitary tumours.

Authors:  P Chanson; J Timsit; A G Harris
Journal:  Clin Pharmacokinet       Date:  1993-11       Impact factor: 6.447

3.  Drug-induced hepatitis following use of octreotide for long-term treatment of congenital hyperinsulinism.

Authors:  Bindu Avatapalle; Raja Padidela; Tabitha Randell; Indraneel Banerjee
Journal:  BMJ Case Rep       Date:  2012-07-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.